To explore the possibilities of fibrinclytic therapy of coronary thrombosis, experimental studies were carried out to document lysis of coronary thrombi and to investigate the effect of fibrinolytic blood upon inyocardial infarction. Serum-induced coronary thrombi were produced by a new technic and were followed by serial coronary arteriography. Control animals were compared to animals in which significant fibrinolytic activity had been induced by systemic infusions of plasmuin. Tissue studies suggest that plasmin may change the evolution of early infarction. Whether these changes will ultimately result in salvage of ischemic tissue will be determined by studies now in progress.
RESTORATION of coronary circulation
It by dissolution of an obstructing thrombus could change the clinical course of myoeardial infarction. Human plasmini (fibrinolysin) is an enzyme that has been shown to b)e effective in the dissolution of clots in peripheral vessels. -6 No data relative to the action of plasmin on experimental or clinical coronary thrombi have been reported.
Ill this first report the method of producing intracoronary thrombi in dogs and of doeumnenting their presence and size by direct serial arteriography will be described. It will be shown by these same objective criteria that these thrombi can be lysed by plasmin (fibrinolysin) in adequate dosage. The effect of the fibrinolytie state and restoration of coronary blood flow upon the histologic structure of early infarction will be discussed. After production of coronary occlusion, the animnals were kept under anesthesia by injection of 30 to 65 iug. of sodium pentobarbital as needed for observation periods up to 15 hours.
METHODS AND MATERIALS
During the experiment the change in clot size was determined at 1 to 2 hour intervals by mneasurement of the length of the filling defects in serial arteriogramis. The final size and configuration of these thromnbi were noted at autopsy and the hearts were then fixed in fornialin for histologic examination. Tissue sections were chosen from the central and marginal zones of the infarets and front the uninvolved wall of the left ventricle.
The clots were observed for at least 8 to 15 hours in the control group and until lysis occurred in the treated animals. The blood of the treated and the untreated animals was examined periodically to determine fibrinolytic activity by the euglobulin method and whole clot lysis time.'
In the treated animals an intravenous infusion of plasmin (fibrinolysin)t was started fromn 1 to 8 hours after production of the coronary thromnbus. fig. 4) . Froni 7 to 15 hours after coronary oeclusion ail average decrease of 20 per cent was observed ill the size of the filling defects, which call be accounted for by clot retraction and possibly minimal lysis. Two of these control animals developed fatal veiltricular fibrillatiomi 2 and 9 hours after occlusion. Dissection of corollary vessels at autopsy confirmed the presence of cylindrical thrombi ill all 7 animals. One additional untreated animal showed spontaneous fibrinolytic activity, which resulted in disappearance of the filling defect after 7 hours.
The control animals were autopsied 10 to 15) hours after corollary oeclusiomi or earlier ill case of fatal complications. The histologic findings consequently refer to the early changes in the infarcted myoeardium. The infarets showed marked interstitial edema, dilatation and congestion of the capillary vessels, scattered focal necrosis of muscle fibers, and marked fibrinous epicarditis with subepicardial leukocytic infiltration. Microthrombi were frequently observed. Figure a shows the marginal zone of a 12 hour old infaret with capillary microthrombi and vascular congestion. More severe changes were observed in the center of the same infarct with heavy edema, shrunken muscle fibers, and marked platelet aggregation in dilated vessels (figf. 6).
Plasmini-Treated Groiup. In the group of 8 amiimals treated with intravenous or intra(oroniary infusiomis of plasmini, objective evidence of lysis was obtained in all (fir. 4). Six were treated intravenously and 2 by intracoronary infusion. Fibrinolvtic activity was induced 1 to 8 hours after coronary occlusion. Within 2 hours after the start of plasmin treatment progressive shortening of the filling defects became apparent. Complete lysis of coroniary thromubi was achieved in 4 animals within 3 to 7 hours. Partial lysis (60 per cenit or more) was observed in 4 dogs. One was killed and revealed a tiny residual (lot at autopsy. Three animals succumbed to complications 3 to a hours after beginiiing of treatment (ventricular fibrillatiomi in 1, shock due to excessive oozing, from the operative wound in 1, ancl injection of pentobarbital in 1).
The progress of lysis of a coroniary thronibus is depicted in the series of arteriograms in figure 3 . The filling defects extending from the arrow point to the metal marker indicate the size of the thrombus. In this experiment total lysis of aii 8 hour old thrombus was achieved after 41/, hours of systemic plasmin infused at a rate of 4,000 units per Kg. per hour.
The animals were autopsied after restoration of patency as shown by the arteriograms, or earlier in the case of fatal complications. The microscopic appearance of the treated hearts was in striking coiitrast to the control hearts of similar duration. Figure 7 is considered representative of a 13 hour old infarct, where coronary circulation had been restored after 6 hours of plasmin treatment. Capillary thrombi and vascular congestion are completely absent. There is moderate edema and some focal muscle cell necrosis with cell invasion.
The predominant tissue changes were graded according to frequency and severity to show the contrast between the treated and the control group ( fig. 8 ). We were unable to find any histologic evidence of damage in the animals treated with plasmin. There was no hemorrhage or evidence of increased necrosis. DIscussIoN
These experiments prove the dissolution of intraeoronary thrombi by the fibrinolytic enzyme, plasmin, within 4 to 8 hours. The composition of these thrombi approximates the constituents of clots in clinical thrombosis.
The speed of lysis is the same as for experimental peripheral venous and arterial (lots.) 6, 8, 9 In man peripheral thrombosis has been successfully treated by plasmin although the speed has not been accurately measured.4 Since successful lysis of thrombi located at various sites of the circulatory system has been proved in animals and man, the feasibility of fibrinolytic therapy in human coronary thrombosis appears established.
The objective of fibrinolytic therapy is restoration of blood flow to organs by lysis of vascular blockade. The chances for success depend upon the tolerance of the organ to isehemia. It is well known that the time limits of viability are quite different in various organs. Earlier studies suggested that temporary coronary occlusion for more than 30 minutes would result in irreversible myocardial damage similar to permanent occlusion.10' 11 However, more recent reports indicate that the duration of ischemia may not be the sole factor determining the time limits of viability. Myocardial anoxia may be tolerated for periods up to 2 hours during hypothermia12 or during perfusion of the heart with heparin-containing solutions.13
The mechanism of ischemic injury has beeni studied in detail by Bing by collateral perfusion. Studies are now ill progress to determine whether rapid restoration of the patency of the capillary bed may influence the viability of the ischemic myocardium by improving the supply of oxygen and metabolic fuels.
Since no deleterious effects of plasmin, such as myocardial rupture or intramyocardial hemorrhage, were observed, we think that our experimental evidence offers a sound rationale for a trial of fibrinolytic therapy of human myocardial infaretion. With the recent development of purified preparations of plasmin for human use, such a study is now possible.
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